November 16-18, 2023
Sheraton Boston Hotel
Boston, Massachusetts

Conference Cochairs

Victoria L. Bae-Jump, University of North Carolina, Chapel Hill, North Carolina
Deborah F. DeLair, Northwell Health, Greenvale, New York
Douglas A. Levine, Merck Research Laboratories, Rahway, New Jersey

Endometrial cancer is the most common cancer of the female reproductive tract and the third most common cause of death among cancers that affect women. Endometrial cancer diagnoses have increased in recent years, and it remains one of the few malignancies with rapidly rising mortality and incidence rates, posing a major public health concern for women worldwide. Rising obesity rates, changing reproductive trends, and disproportionate increases in rare endometrial cancer subtypes, mostly in underrepresented minority populations, are some of the causes of this increased incidence and mortality. Understanding the opportunities for endometrial cancer prevention and better treatment strategies is critical to reversing these concerning trends and maximizing survival for those diagnosed with this disease. The Conference Cochairs have developed a program that will be appealing to both basic scientists and clinical oncologists; participation by the next generation of cancer researchers and caregivers will help better disseminate the field’s rapidly expanding body of research innovations while also igniting potent partnerships. 

Professional Educational Grants

Merck

#AACRec23